We are live on ! Find out more

Novanta

NOVT

Market cap $5.08B

134.31 USD

+1.17

0.88%

At close Updated Sep 21, 4:00 PM EDT

Pre-market

After hours

134.31

0.00

0%

1 day

0.88%

5 days

-5.01%

1 month

-7.53%

3 months

-13.72%

6 months

14.45%

Year to date

20.85%

1 year

18.67%

5 years

-14.63%

10 years

679.06%

About: Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.

Employees: 3,000

Technology Scientific & Technical Instruments

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 55.6%

Neutral 44.4%

Negative 0%

How to Build a Humanoid Body

Last month we broke down the three key areas needed to build your own humanoid. We have already looked at the companies behind the technologies required to build a humanoid's brain.

How to Build a Humanoid Body

Zacks Investment Research

Are Robots the New Normal? Bet on these ETFs to Invest in the Future

Robotics is entering a new era as AI fuels humanoid adoption, with four ETFs offering diversified exposure to the sector's growth.

Are Robots the New Normal? Bet on these ETFs to Invest in the Future

Novanta to Present at Baird Global Healthcare Conference on Tuesday, September 15, 2026

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, and John Lesica, Chief Operating Officer of Medical Solutions, are scheduled to present at the Baird Global Healthcare Conference on Tuesday, September 15, 2026, in New York, NY. About Novanta Novanta is a leading global supplier of core technology solutions that give medical a.

Novanta to Present at Baird Global Healthcare Conference on Tuesday, September 15, 2026

How to Build a Humanoid Brain

In our previous guide to building a humanoid robot, we mapped out the three essential pillars of the project: the brain, the body, and the energy systems. Now, it is time to look closer at the brain.

How to Build a Humanoid Brain

Zacks Investment Research

Recent Price Trend in Novanta (NOVT) is Your Friend, Here's Why

If you are looking for stocks that are well positioned to maintain their recent uptrend, Novanta (NOVT) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Recent Price Trend in Novanta (NOVT) is Your Friend, Here's Why

Zacks Investment Research

Are You Looking for a Top Momentum Pick? Why Novanta (NOVT) is a Great Choice

Does Novanta (NOVT) have what it takes to be a top stock pick for momentum investors? Let's find out.

Are You Looking for a Top Momentum Pick? Why Novanta (NOVT) is a Great Choice

Novanta Q2 Earnings Call Highlights

Novanta NASDAQ: NOVT reported second-quarter results marked by 9% organic sales growth, expanding margins and higher operating cash flow, while raising its full-year outlook following the late-July closing of its Riverpoint Medical acquisition.

Novanta Q2 Earnings Call Highlights

Novanta Inc. (NOVT) Q2 2026 Earnings Call Transcript

Novanta Inc. (NOVT) Q2 2026 Earnings Call Transcript

Novanta Inc. (NOVT) Q2 2026 Earnings Call Transcript

Zacks Investment Research

Novanta (NOVT) Tops Q2 Earnings and Revenue Estimates

Novanta (NOVT) came out with quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of $0.83 per share. This compares to earnings of $0.76 per share a year ago.

Novanta (NOVT) Tops Q2 Earnings and Revenue Estimates

Novanta Announces Financial Results for the Second Quarter 2026

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the second quarter 2026. Financial Highlights Three Months Ended (In millions, except per share amounts) July 3, June 27, 2026 2025 GAAP Revenue $ 265.8 $ 241.0 Operating Income $ 18.1 $ 14.9 Net Income $ 12.5 $ 4.5 Diluted EPS $ 0.30 $ 0.12.

Novanta Announces Financial Results for the Second Quarter 2026

See News Rankings

Price charts implemented using Lightweight Charts™